Targeting TBL1 with tegavivint promotes anti-tumor and immunomodulatory responses in preclinical models of hepatocellular carcinoma

被引：0
|
作者：
Holloway, Kimberly R.
Drake, Thomas
Bird, Thomas
Horrigan, Stephen
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6167
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6167
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
    Yuko Kusakabe
    Tetsuhiro Chiba
    Motohiko Oshima
    Shuhei Koide
    Ola Rizq
    Kazumasa Aoyama
    Junjie Ao
    Tatsuya Kaneko
    Hiroaki Kanzaki
    Kengo Kanayama
    Takahiro Maeda
    Tomoko Saito
    Ryo Nakagawa
    Kazufumi Kobayashi
    Soichiro Kiyono
    Masato Nakamura
    Sadahisa Ogasawara
    Eiichiro Suzuki
    Shingo Nakamoto
    Shin Yasui
    Rintaro Mikata
    Ryosuke Muroyama
    Tatsuo Kanda
    Hitoshi Maruyama
    Jun Kato
    Naoya Mimura
    Anqi Ma
    Jian Jin
    Yoh Zen
    Masayuki Otsuka
    Atsushi Kaneda
    Atsushi Iwama
    Naoya Kato
    Scientific Reports, 11
  • [42] TARGETING EPHB2/ABL1 RESTORES ANTI-TUMOR IMMUNITY IN A PRECLINICAL MODEL OF EPENDYMOMA
    Ren, Jun
    Amoozgar, Zohreh
    Uccello, Taylor P.
    Zhao, Yuhui
    Lei, Pinji
    Ho, William W.
    Roberge, Sylvie
    Huang, Peigen
    Duda, Dan G.
    Xu, Lei
    Jain, Rakesh K.
    NEURO-ONCOLOGY, 2024, 26
  • [43] Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma
    Ren, Jun
    Amoozgar, Zohreh
    Zhao, Yuhui
    Lei, Pinji
    Ho, William W.
    Robergea, Sylvie
    Huang, Peigen
    Duda, Dan G.
    Xu, Lei
    Jain, Rakesh K.
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma
    Uccello, Taylor P.
    Ren, Jun
    Amoozgar, Zohreh
    Zhao, Yuhui
    Lei, Pin-Ji
    Ho, William W.
    Roberge, Sylvie
    Huang, Peigen
    Duda, Dan G.
    Xu, Lei
    Jain, Rakesh K.
    CANCER RESEARCH, 2024, 84 (05)
  • [45] TARGETING LONP1 ACTIVITY IN HUMAN MACROPHAGES PROMOTES AN ANTI-TUMOR RESPONSE IN BREAST CANCERS
    Ostroot, C.
    Rodriguez, T.
    Mohamed, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 146 - 146
  • [46] Anti-tumor Efficacy of a Hepatocellular Carcinoma Vaccine Based on Dendritic Cells Combined with Tumor-derived Autophagosomes in Murine Models
    Su, Shu
    Zhou, Hao
    Xue, Meng
    Liu, Jing-Yu
    Ding, Lei
    Cao, Meng
    Zhou, Zhen-Xian
    Hu, Hong-Min
    Wang, Li-Xin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 3109 - 3116
  • [47] Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers
    Mohammed A. F. Elewa
    Mohammed M. Al-Gayyar
    Mona F. Schaalan
    Khaled H. Abd El Galil
    Mohamed A. Ebrahim
    Mamdouh M. El-Shishtawy
    Clinical & Experimental Metastasis, 2015, 32 : 479 - 493
  • [48] Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers
    Elewa, Mohammed A. F.
    Al-Gayyar, Mohammed M.
    Schaalan, Mona F.
    Abd El Galil, Khaled H.
    Ebrahim, Mohamed A.
    El-Shishtawy, Mamdouh M.
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (05) : 479 - 493
  • [49] Synergistic and additive anti-tumor effects of MIV-818 in combination with sorafenib in nonclinical hepatocellular carcinoma models
    Rizoska, Biljana
    Bylund, Johan
    Briem, Sveinn
    Kyle, Alastair
    Minchinton, Andrew
    Oberg, Fredrik
    Gohlin, Karin
    Albertella, Mark
    CANCER RESEARCH, 2018, 78 (13)
  • [50] siRNA targeting PD-L1 delivered with attenuated Salmonella enhanced the anti-tumor effect of lenvatinib on mice bearing Hepatocellular carcinoma
    Chen, Pengfei
    Li, Yingjing
    Wei, Pengkun
    Liang, Lirui
    Li, Baozhu
    Cao, Yuhao
    Han, Xinwei
    Wang, Yanling
    Duan, Xuhua
    Jia, Huijie
    Zhao, Tieuso
    Ren, Jianzhuang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
12345